Global life sciences outlook
Amid the tragic consequences of COVID-19, life sciences and medtech companies emerged as lights in the darkness. Decades of scientific work and investment seemed to be overnight successes.
'White Papers' is specialized section provide real, actionable information to prospects. Done well, they shorten sales cycles, educate prospects and showcase a company’s thought leadership. White papers are hosted behind a registration-based landing page that captures key lead scoring information.
White Paper publication program on pharmatechglobal.net benefit from our integrated audience database. Registration can be pre-populated based on our database of professionals, providing for superior conversion rates. — If interested, Post your company's White Papers here
Amid the tragic consequences of COVID-19, life sciences and medtech companies emerged as lights in the darkness. Decades of scientific work and investment seemed to be overnight successes.
Life sciences businesses have accelerated their digital-first journey to survive and thrive in a world where time-to-everything matters more than any other strategic imperative, according to our study.
Advances in AI & machine learning, combined with healthcare data from pharmacies, insurers, healthcare professionals (HCP), labs, marketing campaigns, and social media, can provide them with that competitive edge.
Increasing data volumes as well as increasing data complexity are currently forcing the drug safety industry to look for solutions to reduce case processing costs...
Large segments of the population are at high risk of vitamin deficiencies, and deficiencies can emerge because of certain disease states, therapeutic interventions, and even hospitalization itself.